- Home
- NVO vs ABT Comparison
NVO vs ABT Comparison
Compare NVO & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVO
- ABT
- Stock Information
- Founded
- NVO 1923
- ABT 1888
- Country
- NVO Denmark
- ABT United States
- Employees
- NVO N/A
- ABT N/A
- Industry
- NVO Biotechnology: Biological Products (No Diagnostic Substances)
- ABT Medical/Dental Instruments
- Sector
- NVO Health Care
- ABT Health Care
- Exchange
- NVO Nasdaq
- ABT Nasdaq
- Market Cap
- NVO 278.0B
- ABT 237.4B
- IPO Year
- NVO N/A
- ABT N/A
- Fundamental
- Price
- NVO $67.23
- ABT $131.45
- Analyst Decision
- NVO Buy
- ABT Buy
- Analyst Count
- NVO 3
- ABT 18
- Target Price
- NVO $112.00
- ABT $142.28
- AVG Volume (30 Days)
- NVO 7.7M
- ABT 6.0M
- Earning Date
- NVO 08-06-2025
- ABT 07-17-2025
- Dividend Yield
- NVO 1.76%
- ABT 1.79%
- EPS Growth
- NVO 17.93
- ABT 139.92
- EPS
- NVO 3.40
- ABT 7.70
- Revenue
- NVO $43,922,211,349.00
- ABT $42,344,000,000.00
- Revenue This Year
- NVO $18.59
- ABT $7.56
- Revenue Next Year
- NVO $15.61
- ABT $7.73
- P/E Ratio
- NVO $19.76
- ABT $17.08
- Revenue Growth
- NVO 24.11
- ABT 5.00
- 52 Week Low
- NVO $57.00
- ABT $99.71
- 52 Week High
- NVO $143.49
- ABT $141.23
- Technical
- Relative Strength Index (RSI)
- NVO 39.83
- ABT 41.48
- Support Level
- NVO $68.65
- ABT $131.26
- Resistance Level
- NVO $71.75
- ABT $135.05
- Average True Range (ATR)
- NVO 1.50
- ABT 2.30
- MACD
- NVO -0.32
- ABT -0.45
- Stochastic Oscillator
- NVO 10.32
- ABT 13.26
About NVO Novo Nordisk A/S
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
About ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.